Logo image of 1CROX.MI

CROCS INC (1CROX.MI) Stock Fundamental Analysis

BIT:1CROX - Euronext Milan - US2270461096 - Common Stock - Currency: EUR

101.12  +101.12 (+Infinity%)

Fundamental Rating

7

1CROX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 42 industry peers in the Textiles, Apparel & Luxury Goods industry. 1CROX gets an excellent profitability rating and is at the same time showing great financial health properties. 1CROX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make 1CROX suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

1CROX had positive earnings in the past year.
In the past year 1CROX had a positive cash flow from operations.
1CROX had positive earnings in each of the past 5 years.
In the past 5 years 1CROX always reported a positive cash flow from operatings.
1CROX.MI Yearly Net Income VS EBIT VS OCF VS FCF1CROX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

1CROX has a Return On Assets of 18.90%. This is amongst the best in the industry. 1CROX outperforms 92.86% of its industry peers.
The Return On Equity of 1CROX (48.63%) is better than 95.24% of its industry peers.
The Return On Invested Capital of 1CROX (17.52%) is better than 88.10% of its industry peers.
1CROX had an Average Return On Invested Capital over the past 3 years of 18.73%. This is significantly above the industry average of 10.55%.
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROIC 17.52%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)18.73%
ROIC(5y)24.73%
1CROX.MI Yearly ROA, ROE, ROIC1CROX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

Looking at the Profit Margin, with a value of 23.35%, 1CROX belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
1CROX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 24.84%, 1CROX belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
1CROX's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 59.25%, 1CROX perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
1CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
1CROX.MI Yearly Profit, Operating, Gross Margins1CROX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

1CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 1CROX has been reduced compared to 1 year ago.
The number of shares outstanding for 1CROX has been reduced compared to 5 years ago.
The debt/assets ratio for 1CROX has been reduced compared to a year ago.
1CROX.MI Yearly Shares Outstanding1CROX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
1CROX.MI Yearly Total Debt VS Total Assets1CROX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.83 indicates that 1CROX is not in any danger for bankruptcy at the moment.
1CROX has a better Altman-Z score (3.83) than 76.19% of its industry peers.
1CROX has a debt to FCF ratio of 1.68. This is a very positive value and a sign of high solvency as it would only need 1.68 years to pay back of all of its debts.
1CROX's Debt to FCF ratio of 1.68 is amongst the best of the industry. 1CROX outperforms 88.10% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that 1CROX is somewhat dependend on debt financing.
1CROX has a Debt to Equity ratio (0.75) which is in line with its industry peers.
Even though the debt/equity ratio score it not favorable for 1CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Altman-Z 3.83
ROIC/WACC1.74
WACC10.07%
1CROX.MI Yearly LT Debt VS Equity VS FCF1CROX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

1CROX has a Current Ratio of 1.52. This is a normal value and indicates that 1CROX is financially healthy and should not expect problems in meeting its short term obligations.
1CROX's Current ratio of 1.52 is in line compared to the rest of the industry. 1CROX outperforms 59.52% of its industry peers.
A Quick Ratio of 0.97 indicates that 1CROX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.97, 1CROX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
1CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.97
1CROX.MI Yearly Current Assets VS Current Liabilites1CROX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.55% over the past year.
The Earnings Per Share has been growing by 51.64% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 2.09% in the past year.
Measured over the past years, 1CROX shows a very strong growth in Revenue. The Revenue has been growing by 27.23% on average per year.
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%

3.2 Future

The Earnings Per Share is expected to grow by 3.74% on average over the next years.
Based on estimates for the next years, 1CROX will show a small growth in Revenue. The Revenue will grow by 3.08% on average per year.
EPS Next Y-0.34%
EPS Next 2Y1.63%
EPS Next 3Y0.94%
EPS Next 5Y3.74%
Revenue Next Year2.21%
Revenue Next 2Y2.66%
Revenue Next 3Y2.47%
Revenue Next 5Y3.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CROX.MI Yearly Revenue VS Estimates1CROX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
1CROX.MI Yearly EPS VS Estimates1CROX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.72, the valuation of 1CROX can be described as reasonable.
88.10% of the companies in the same industry are more expensive than 1CROX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 1CROX to the average of the S&P500 Index (26.20), we can say 1CROX is valued rather cheaply.
The Price/Forward Earnings ratio is 8.43, which indicates a very decent valuation of 1CROX.
1CROX's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1CROX is cheaper than 95.24% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1CROX to the average of the S&P500 Index (22.13), we can say 1CROX is valued rather cheaply.
Industry RankSector Rank
PE 8.72
Fwd PE 8.43
1CROX.MI Price Earnings VS Forward Price Earnings1CROX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

1CROX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1CROX is cheaper than 61.90% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1CROX is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.26
EV/EBITDA 7.09
1CROX.MI Per share data1CROX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

1CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y1.63%
EPS Next 3Y0.94%

0

5. Dividend

5.1 Amount

No dividends for 1CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

BIT:1CROX (5/20/2025, 7:00:00 PM)

101.12

+101.12 (+Infinity%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners100.85%
Inst Owner ChangeN/A
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap5.67B
Analysts80.91
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.88%
Min EPS beat(2)9.31%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)12.98%
Min EPS beat(4)9.31%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)14.09%
EPS beat(12)12
Avg EPS beat(12)14.76%
EPS beat(16)16
Avg EPS beat(16)17.35%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.88%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)1.22%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)7
Avg Revenue beat(12)0.52%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.72
Fwd PE 8.43
P/S 1.56
P/FCF 7.26
P/OCF 6.73
P/B 3.26
P/tB N/A
EV/EBITDA 7.09
EPS(TTM)11.6
EY11.47%
EPS(NY)12
Fwd EY11.87%
FCF(TTM)13.93
FCFY13.77%
OCF(TTM)15.02
OCFY14.85%
SpS64.63
BVpS31.04
TBVpS-8.12
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROCE 23.35%
ROIC 17.52%
ROICexc 18.21%
ROICexgc 44.67%
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
FCFM 21.55%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)18.73%
ROIC(5y)24.73%
ROICexc(3y)19.58%
ROICexc(5y)28.15%
ROICexgc(3y)57.87%
ROICexgc(5y)51.82%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Debt/EBITDA 1.36
Cap/Depr 95.51%
Cap/Sales 1.68%
Interest Coverage 11.16
Cash Conversion 87.36%
Profit Quality 92.29%
Current Ratio 1.52
Quick Ratio 0.97
Altman-Z 3.83
F-Score6
WACC10.07%
ROIC/WACC1.74
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
EPS Next Y-0.34%
EPS Next 2Y1.63%
EPS Next 3Y0.94%
EPS Next 5Y3.74%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%
Revenue Next Year2.21%
Revenue Next 2Y2.66%
Revenue Next 3Y2.47%
Revenue Next 5Y3.08%
EBIT growth 1Y-4.07%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-0.47%
EBIT Next 3Y-3.04%
EBIT Next 5Y4.44%
FCF growth 1Y53.79%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y39.75%
OCF growth 3Y20.5%
OCF growth 5Y61.62%